KALA
KALA BIO, Inc.
There isn't enough reported data to score KALA yet.
UNH
UnitedHealth Group Incorporated
UNH's fundamentals are mixed: free cash flow grew 31%, but earnings per share fell 8.5%. At 23x earnings, it's trading right at its usual valuation. Analysts expect strong earnings growth, though they disagree widely on how much.
KALA Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Weak | |
| Unavailable | |
| Unavailable |
KALA's revenue and profitability are currently weak. There isn't enough data to rate its cash flow and balance sheet.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
KALA PE Valuation
KALA has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
KALA Forward outlook
There aren't enough analyst estimates for KALA to show an outlook.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
KALA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2025 | -$204.63 | +$302.87 |
| Q3 2025 | -$252.50 | +$341.50 |
| Q2 2025 | -$295.50 | +$372.50 |
| Q1 2025 | -$368.00 | +$360.00 |
| Q4 2024 | -$507.50 | +$360.00 |
| Q3 2022 | -$2,862.50 | +$2,237.50 |
| Q2 2022 | -$4,900.00 | +$375.00 |
| Q1 2022 | -$5,375.00 | -$475.00 |
UNH has the stronger earnings trend. Trailing diluted EPS is down 140% for KALA versus UNH down 8.5%.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH's earnings per share have fallen from their peak: $17.55 over the past year, against $23.89 in early 2025.
KALA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2022 | $420K | -86% |
| Q2 2022 | $2.1M | -31% |
| Q1 2022 | $1.4M | -58% |
| Q4 2021 | $1.9M | -17% |
| Q3 2021 | $3.1M | +38% |
| Q2 2021 | $3.1M | +266% |
| Q1 2021 | $3.3M | +205% |
| Q4 2020 | $2.2M | +90% |
UNH has the stronger quarterly revenue trend. Revenue is down 100% for KALA versus down 0.4% for UNH.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2022 | -3469% | -2619 points |
| Q2 2022 | -1237% | -285 points |
| Q1 2022 | -2253% | -1386 points |
| Q4 2021 | -2522% | -1227 points |
| Q3 2021 | -850% | +314 points |
| Q2 2021 | -952% | +1603 points |
| Q1 2021 | -867% | +1012 points |
| Q4 2020 | -1295% | +417 points |
KALA's operating margin was −3469% last quarter, down 2619 points from the same quarter a year ago, near the bottom of its range since 2019.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH's revenue has held roughly level: $113B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH's operating margin was 5.8% last quarter, up 2 points from the same quarter a year ago.
KALA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$1.5M | +$15M |
| Q1 2026 | -$2.9M | +$5.9M |
| Q4 2025 | -$4.6M | +$42K |
| Q3 2025 | -$10.9M | -$6.2M |
| Q2 2025 | -$16.6M | -$7.3M |
| Q1 2025 | -$8.8M | +$2M |
| Q4 2024 | -$4.6M | +$3.1M |
| Q3 2024 | -$4.7M | -$1.8M |
KALA has burned cash in almost every quarter: −$20M over the past year, against −$35M the year before.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over KALA on cash generation, producing positive trailing cash flow while its opponent burns cash.
KALA Net Leverage
KALA's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
KALA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 4.7 | Oversold |
KALA's weekly RSI is 33 (neutral) and its Stochastic is 5 (oversold).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
KALA PE vs Healthcare Sector
KALA has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
KALA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.25 | 36% below |
| 20 week MA | $0.59 | 73% below |
| 50 week MA | $9.99 | 98% below |
| 100 week MA | $160.4 | 100% below |
| 200 week MA | $321.9 | 100% below |
KALA is in a downtrend: it's below all five of its weekly moving averages, and 100% below its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over KALA on trend strength, trading above more of its moving averages.
KALA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9,325.0 | $19,150.0 | +105% |
| 2021 | $19,150.0 | $3,400.0 | -82% |
| 2022 | $3,400.0 | $194.0 | -94% |
| 2023 | $194.0 | $350.0 | +80% |
| 2024 | $350.0 | $349.0 | -0.3% |
| 2025 | $349.0 | $32.5 | -91% |
| 2026 YTD | $32.5 | $0.16 | -100% |
KALA's yearly returns have swung widely, from +105% in 2020 to −94% in 2022. It's down 100% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over KALA on returns for 2026, with the stronger performance.